Cantor Fitzgerald downgrades Sunesis Pharmaceuticals (NASDAQ: SNSS) from Buy to Hold and lowers their price target from $6.00 to $2.50.
This article: 132 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE